BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 32289462)

  • 21. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
    Jasemi S; Douraghi M; Adibhesami H; Zeraati H; Rahbar M; Boroumand MA; Aliramezani A; Ghourchian S; Mohammadzadeh M
    Lett Appl Microbiol; 2016 Dec; 63(6):466-472. PubMed ID: 27626896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial effect of photodynamic therapy using erythrosine/methylene blue combination on Streptococcus mutans biofilm.
    Tokubo LM; Rosalen PL; de Cássia Orlandi Sardi J; Freires IA; Fujimaki M; Umeda JE; Barbosa PM; Tecchio GO; Hioka N; de Freitas CF; Suga Terada RS
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():94-98. PubMed ID: 29763739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii clinical isolates.
    Ricciardi R; Ricciardi AM; Danzi G
    Infez Med; 2009 Dec; 17(4):236-9. PubMed ID: 20046104
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Flamm RK; Shortridge D; Castanheira M; Sader HS; Pfaller MA
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
    Keskin H; Tekeli A; Dolapci İ; Öcal D
    Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attaching NorA efflux pump inhibitors to methylene blue enhances antimicrobial photodynamic inactivation of Escherichia coli and Acinetobacter baumannii in vitro and in vivo.
    Rineh A; Bremner JB; Hamblin MR; Ball AR; Tegos GP; Kelso MJ
    Bioorg Med Chem Lett; 2018 Sep; 28(16):2736-2740. PubMed ID: 29519734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colistin/daptomycin: an unconventional antimicrobial combination synergistic in vitro against multidrug-resistant Acinetobacter baumannii.
    Galani I; Orlandou K; Moraitou H; Petrikkos G; Souli M
    Int J Antimicrob Agents; 2014 Apr; 43(4):370-4. PubMed ID: 24560919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit.
    Ceccarelli G; Oliva A; d'Ettorre G; D'Abramo A; Caresta E; Barbara CS; Mascellino MT; Papoff P; Moretti C; Vullo V; Visca P; Venditti M
    BMC Infect Dis; 2015 Sep; 15():393. PubMed ID: 26424078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii.
    Housman ST; Hagihara M; Nicolau DP; Kuti JL
    J Antimicrob Chemother; 2013 Oct; 68(10):2296-304. PubMed ID: 23710070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative assessment of antimicrobial susceptibility testing for tigecycline and colistin against Acinetobacter baumannii clinical isolates, including multidrug-resistant isolates.
    Piewngam P; Kiratisin P
    Int J Antimicrob Agents; 2014 Nov; 44(5):396-401. PubMed ID: 25442358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In vitro tigecycline and carbapenem susceptibilities of clinical Acinetobacter baumannii isolates].
    Nayman Alpat S; Aybey AD; Akşit F; Ozgüneş I; Kiremitçi A; Usluer G
    Mikrobiyol Bul; 2010 Oct; 44(4):641-5. PubMed ID: 21063976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study.
    McCracken M; Mataseje LF; Loo V; Walkty A; Adam HJ; Hoban DJ; Zhanel GG; Mulvey MR;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):335-41. PubMed ID: 21353962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The combination of antimicrobial photocatalysis and antimicrobial photodynamic therapy to eradicate the extensively drug-resistant colistin resistant Acinetobacter baumannii.
    Boluki E; Pourhajibagher M; Bahador A
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101816. PubMed ID: 32404300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Piscidin is highly active against carbapenem-resistant Acinetobacter baumannii and NDM-1-producing Klebsiella pneumonia in a systemic Septicaemia infection mouse model.
    Pan CY; Chen JC; Chen TL; Wu JL; Hui CF; Chen JY
    Mar Drugs; 2015 Apr; 13(4):2287-305. PubMed ID: 25874924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacodynamics of tigecycline alone and in combination with colistin against clinical isolates of multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model.
    Cai X; Yang Z; Dai J; Chen K; Zhang L; Ni W; Wei C; Cui J
    Int J Antimicrob Agents; 2017 May; 49(5):609-616. PubMed ID: 28315729
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Soudeiha MAH; Dahdouh EA; Azar E; Sarkis DK; Daoud Z
    Front Cell Infect Microbiol; 2017; 7():209. PubMed ID: 28596943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence of tigecycline and colistin resistance in Acinetobacter species isolated from patients in Kuwait hospitals.
    Al-Sweih NA; Al-Hubail MA; Rotimi VO
    J Chemother; 2011 Feb; 23(1):13-6. PubMed ID: 21482488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virulence profiles and innate immune responses against highly lethal, multidrug-resistant nosocomial isolates of Acinetobacter baumannii from a tertiary care hospital in Mexico.
    Rosales-Reyes R; Gayosso-Vázquez C; Fernández-Vázquez JL; Jarillo-Quijada MD; Rivera-Benítez C; Santos-Preciado JI; Alcántar-Curiel MD
    PLoS One; 2017; 12(8):e0182899. PubMed ID: 28797068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High prevalence of multidrug resistance and metallo-beta-lactamase (MβL) producing Acinetobacter baumannii isolated from patients in ICU wards, Hamadan, Iran.
    Safari M; Saidijam M; Bahador A; Jafari R; Alikhani MY
    J Res Health Sci; 2013 Sep; 13(2):162-7. PubMed ID: 24077474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.